Additionally, GLP-1 can slow down the process of gastric emptying and gastrointestinal movement, which consequently lowers glucose absorption, regulating the postprandial glucose concentration
lactis MG1363-pMG36e-GLP-1 on Parkinson's disease via inhibiting Ferroptosis
Specifically, the effect of GLP-1 RAs in reducing the risk of mood disorders may not be related to their hypoglycemic mechanism
These drugs originated as treatments for patients with type 2 diabetes, and although they are all classified as GLP-1 RAs, there are small, molecular differences between them
Circulation, scalp comfort, balance, and the natural growth cycle all supported in a single application
Int J Mol Sci 24(13):10915